Vorträge und Veröffentlichungen

bisherige Vorträge...

1.

bisherige Vorträge...

Spiritualität in der Medizin und Therapie. State of the Art –Eröffnungsvortrag
Musiktherapietagung , München; 5.3.2016

Spiritualität in der Medizin und Therapie. Sinn oder Unsinn?
kbo Isar Amper Klinikum München Ost; 5.11.2014

Mystik und Aberglaube; Spirituelle Führung oder Verführung?
13. El Haddawi International Winterschool, 13.-16.2.2013, Fraueninsel Chiemgau

Burnout- Herzinfakt der Seele; Immer begeistert, immer einsatzbereit, immer erfolgreich?
E.ON; 17.1.2013 Hamburg

Spiritualität als Wettbewerbsfaktor im 21. Jahrhundert, Halbtagesworkshop
Kanzlei Fritz und Schauer; 22.11.2012 Innsbruck

Die Modeerscheinung Burnout. Wie schwimmen sie erfolgreich gegen den Strom.
Herbstimpulse 2012; Kanzlei Fritz und Schauer; 8.10.2012 Innsbruck

Unterschiedliche Anforderungsprofile an den psychiatrischen Konsilar- und Laisiondienst
Forschungskongress 30.9.2011, Irrsee

Psychiatrische Symptome in der Notaufnahme
Bogenhausener Minisymposium; 2.3.2011 München

„Woman meets Woman“ Vortrag und Workshop: Neurobiology & Spirituality
weibliche Topführungskandidaten in der Armee; Norwegen, Oslo; 2007

2x jährlich Einführung in den psychiatrischen Konsildienst+ 2x Fallvorstellung
kbo Isar Amper Klinikum München Ost, 2007-20014

Körperpsychotherapie und Spiritualität: Therapie & Praxis
Fortbildungsprogramm Adulaklinik; Oberstdorf , 2004

Corticotropin-releasing hormone receptor 1 antagonism counteracts sleep-EEG changes in depression Regionaltreffen AGNP; Sölden 2002

Changes in endocrinology under treatmeant with the CRH1-receptor antagonist R121919
AGNP-Smposium; Breslau, 2002

„How real is reality“ – Wissenschaft & mystische Erfahrungen
Core-Convention „Unifying the dimension of life“ USA; Kalifornien, 2001

Arginin improves sleep in elderly men
21 AGNP- Symposium; Nürnberg 2001

Sleep endocrine effects of growth hormone-releasing hormone (GHRH) in patients with obsessive-compulsive disorder (OCD) 21 AGNP- Symposium; Nürnberg 1999;

Mg 2+ reverses age related sleep-endocrine changes in elderly
DGE; München, 2000

Neuropeptid Y (NPY) does not differentially affect sleep-endocrine regulation in depressed patients and controls AGNP-Symposium; Nürnberg, 1999

2.

bisherige - nicht wissenschaftlichen - Veröffentlichungen

Dimensionen der Wahrnehmung; 11/ 2012;
www.kgsberlin.de/archiv/eintrag/art78312.html

Sinn und R-evolution;  Orhideal Magazin 6-2012
www.orhideal-image.com/_orhideal/pdf/2012-06-IMAGE.pdf

3.

bisherige wissenschaftliche Publikationen….

Sleep-endocrine effects of growth hormone-releasing hormone (GHRH) in patients with schizophrenia. Künzel HE, Held K,  Schmidt D, Ziegenbein M, Murck H, , Steiger A.    J Psychiatr Res. 2018 Juni; Vol 1, 1-4;

Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol–a double-blind multicenter trial.
Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, , Yassouridis A, Holsboer F, Steiger A.
J Psychiatr Res. 2009 Apr;43(7):702-10.

Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women.
Schüssler P, Kluge M, Yassouridis A, Dresler M, Held K, Zihl J, Steiger A.
Psychoneuroendocrinology. 2008 Sep;33(8):1124-31..

Systemic growth hormone-releasing hormone (GHRH) impairs sleep in healthy young women.
Mathias S, Held K, Ising M, Weikel JC, Yassouridis A, Steiger A.
Psychoneuroendocrinology. 2007 Sep-Nov;32(8-10):1021-7.

Nocturnal ghrelin, ACTH, GH and cortisol secretion after sleep deprivation in humans.
Schüssler P, Uhr M, Ising M, Weikel JC, Schmid DA, Held K, Mathias S, Steiger A.
Psychoneuroendocrinology. 2006 Sep;31(8):915-23.

Renin-angiotensin-aldosterone system, HPA-axis and sleep-EEG changes in unmedicated patients with depression after total sleep deprivation.
Murck H, Uhr M, Ziegenbein M, Künzel H, Held K, Antonijevic IA, Schüssler P, Steiger A.
Pharmacopsychiatry. 2006 Jan;39(1):23-9

Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine.
Schmid DA, Wichniak A, Uhr M, Ising M, Brunner H, Held K, Weikel J, Sonntag A, Steiger A.
Neuropsychopharmacology. 2006 Apr;31(4):832-44

Neuropeptide Y (NPY) shortens sleep latency but does not suppress ACTH and cortisol in depressed patients and normal controls.
Held K, Antonijevic I, Murck H, Kuenzel H, Steiger A.
Psychoneuroendocrinology. 2006 Jan;31(1):100-7.

Alpha-helical CRH exerts CRH agonistic effects on sleep-endocrine activity in humans.
Held K, Antonijevic I, Murck H, Künzel H, Steiger A. Neuropsychobiology. 2005;52(2):62-7.

Changes in sleep electroencephalogram and nocturnal hormone secretion after administration of the antidyskinetic agent sarizotan in healthy young male volunteers.
Kuenzel HE, Steiger A, Held K, Antonijevic IA, Frieboes RM, Murck H. Psychopharmacology (Berl). 2005 Jul;180(2):327-32.

Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls.
Schmid DA, Held K, Ising M, Uhr M, Weikel JC, Steiger A.
Neuropsychopharmacology. 2005 Jun;30(6):1187-92

Reboxetine induces similar sleep-EEG changes like SSRI’s in patients with depression.
Kuenzel HE, Murck H, Held K, Ziegenbein M, Steiger A.
Pharmacopsychiatry. 2004 Sep;37(5):193-5

Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG.
Murck H, Held K, Ziegenbein M, Künzel H, Holsboer F, Steiger A.
Psychoneuroendocrinology. 2004 Oct;29(9):1205-11

Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers.
Frieboes RM, Antonijevic IA, Held K, Murck H, Pollmächer T, Uhr M, Steiger A.
Psychoneuroendocrinology. 2004 Aug;29(7):851-60

Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression.
Held K, Künzel H, Ising M, Schmid DA, Zobel A, Murck H, Holsboer F, Steiger A.
J Psychiatr Res. 2004 Mar-Apr;38(2):129-36.

The renin-angiotensin-aldosterone system in patients with depression compared to controls–a sleep endocrine study.
Murck H, Held K, Ziegenbein M, Künzel H, Koch K, Steiger A.
BMC Psychiatry. 2003 Oct 29;3:15

The somatostatin analogue octreotide impairs sleep and decreases EEG sigma power in young male subjects.
Ziegenbein M, Held K, Kuenzel HE, Murck H, Antonijevic IA, Steiger A.
Neuropsychopharmacology. 2004 Jan;29(1):146-51

Ghrelin promotes slow-wave sleep in humans.
Weikel JC, Wichniak A, Ising M, Brunner H, Friess E, Held K, Mathias S, Schmid DA, Uhr M, Steiger A. Am J Physiol Endocrinol Metab. 2003 Feb;284(2):E407-15.

Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans.
Held K, Antonijevic IA, Künzel H, Uhr M, Wetter TC, Golly IC, Steiger A, Murck H.
Pharmacopsychiatry. 2002 Jul;35(4):135-43.

Nocturnal secretion of TSH and ACTH in male patients with depression and healthy controls.
Peteranderl C, Antonijevic IA, Steiger A, Murck H, Held K, Frieboes RM, Uhr M, Schaaf L.
J Psychiatr Res. 2002 May-Jun;36(3):189-96

Zugänglichkeit